Skip to main content

Zosano Pharma Corporation (ZSAN)

NASDAQ: ZSAN · IEX Real-Time Price · USD
0.525
-0.049 (-8.47%)
At close: Dec 3, 2021 4:00 PM
0.539
0.014 (2.628%)
After-hours:Dec 3, 2021 7:55 PM EST
Market Cap62.14M
Revenue (ttm)922,000
Net Income (ttm)-31.05M
Shares Out118.35M
EPS (ttm)-0.29
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,460,015
Open0.579
Previous Close0.574
Day's Range0.519 - 0.590
52-Week Range0.519 - 3.060
Beta3.28
AnalystsBuy
Price Target2.00 (+280.9%)
Earnings DateNov 12, 2021

About ZSAN

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

IndustryHealth Care Equipment & Supplies
IPO DateJan 27, 2015
CEOSteven Lo
Employees45
Stock ExchangeNASDAQ
Ticker SymbolZSAN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for Zosano Pharma stock is "Buy." The 12-month stock price forecast is 2.00, which is an increase of 280.88% from the latest price.

Price Target
$2.00
(280.88% upside)
Analyst Consensus: Buy

News

Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option...

4 days ago - GlobeNewsWire

Today's Hot Penny Stocks: What's Moving ZSAN, AVGR and CEI Higher Wednesday?

Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! The post Today's Hot Penny Stocks: What's Moving ZSAN, AVGR a...

Other symbols:AVGRCEI
2 weeks ago - InvestorPlace

Zosano Pharma Corporation (ZSAN) Reports Q3 Loss, Misses Revenue Estimates

Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -10.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s...

3 weeks ago - Zacks Investment Research

Zosano Pharma Reports Third Quarter 2021 Financial Results

FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended Sept...

3 weeks ago - GlobeNewsWire

Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Phar...

FREMONT, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the company has been granted a Type C written resp...

2 months ago - GlobeNewsWire

Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, S...

3 months ago - GlobeNewsWire

Zosano Pharma Corporation (ZSAN) Reports Q2 Loss, Misses Revenue Estimates

Zosano Pharma Corporation (ZSAN) delivered earnings and revenue surprises of 0.00% and -30.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Zosano Pharma Reports Second Quarter 2021 Financial Results

FREMONT, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended Jun...

3 months ago - GlobeNewsWire

7 Most Promising Penny Stocks to Achieve Your Multibagger Dreams

Penny stocks are a great entry into the market. Here are seven that have the potential to provide quick returns with their strong catalysts.

Other symbols:GPLREISENSXELA
4 months ago - InvestorPlace

Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the ...

FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has been granted an additional patent cove...

4 months ago - GlobeNewsWire

3 Biopharma Penny Stocks That Could be Millionaire Makers

These three biotech penny stocks all have developed drugs that have shown strong indications of success. The post 3 Biopharma Penny Stocks That Could be Millionaire Makers appeared first on InvestorPlace.

Other symbols:CLSNVTVT
4 months ago - InvestorPlace

Buying Biotech Penny Stocks? 3 Trading Tips And 7 To Watch

Are biotech penny stocks worth it? Here's 3 tips for investing and 7 small-caps to watch The post Buying Biotech Penny Stocks?

Other symbols:CTXRJAGXOCGNOPKVTVT
5 months ago - PennyStocks

ZSAN Stock: Why Zosano Pharma Is Racing Higher Today

ZSAN stock is zooming higher on Thursday after Zosano Pharma shared positive data on its proprietary migraine treatment. The post ZSAN Stock: Why Zosano Pharma Is Racing Higher Today appeared first on I...

6 months ago - InvestorPlace

Zosano Stock Surges After New Study Shows Qtrypta's Potential As Long-Term Treatment Option For Migraine

Nano-cap Zosano Pharma Corporation (NASDAQ: ZSAN) has announced that long-term data for Qtrypta, as an acute treatment of migraine, published in The Journal of Headache and Pain. The tolerability and ef...

6 months ago - Benzinga

Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acu...

FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article titled, “Long Term Safety, Tolerabi...

6 months ago - GlobeNewsWire

Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors

FREMONT, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the appointment of Kathy McGee, an accomplished bio...

6 months ago - GlobeNewsWire

Zosano Pharma Reports First Quarter 2021 Financial Results

FREMONT, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March...

6 months ago - GlobeNewsWire

3 Penny Stocks to Watch During the Last Week of April

As April comes to an end, are these 3 penny stocks worth watching? The post 3 Penny Stocks to Watch During the Last Week of April appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols:AEZSMICT
7 months ago - PennyStocks

7 Reddit Penny Stocks to Buy for a Biotech Boom

So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.

7 months ago - InvestorPlace

7 Reddit Penny Stocks to Keep Your Eye on for Big Movement

Reddit stocks -- and in particular Reddit penny stocks -- are some of the riskiest shares out there. Yet, investors could make out big with some of the names on this list.

Other symbols:LPCNOGISNDLSVRAYVRZOM
8 months ago - InvestorPlace

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results

FREMONT, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year...

8 months ago - GlobeNewsWire

Zosano Pharma to Present at the H.C. Wainwright Global Life Sciences Conference

FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, S...

9 months ago - GlobeNewsWire

Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA

FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the official Type A ...

9 months ago - GlobeNewsWire

ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly Higher

Zosano Pharma (ZSAN) stock is flying high on Tuesday with heavy trading despite there being a lack of news about the company. The post ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly High...

9 months ago - InvestorPlace

Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines

FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtrypta™, Zosa...

10 months ago - GlobeNewsWire